Monday, 5 December 2022

Lupin Launches Rufinamide Tablets USP in the United States

Lupin Launches Rufinamide Tablets USP in the United States
Lupin Launches Rufinamide Tablets USP in the United States
Pradip Mahajan Mon, 12/05/2022 - 15:37

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The Company develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.



source https://www.pharmatutor.org/pharma-news/2022/lupin-launches-rufinamide-tablets-usp-in-the-united-states

No comments:

Post a Comment

Pharma openings

  Opportunity for M.Pharm, Msc or PhD as Scientist at PGIMER M.Pharmacy or M.Sc 6 Year of Research Experience or PhD with 3 year of Experien...